PACTR201310000484185Completed未知
Artemether-lumefantrine versus Artesunate-amodiaquine for treatment of uncomplicated plasmodium falciparum malaria in pregnancy; A randomized control trial.
kah Chukwuemeka Marcel0 sites150 target enrollmentStarted: January 15, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 150
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Year(s) to 49 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •1.Symptoms of malaria such as fever (T 37.5oc), headaches, body pains within 24 hours before presentation.
- •2.Microscopically-confirmed P. falciparum malaria with parasitaemia of at least one plus (1-10 parasites/100 thick film field).
- •3.Consent to participate in the study
- •4.Willingness/ability to comply with follow-up schedule
Exclusion Criteria
- •1.Severe malaria or danger signs of severe malaria (e.g. loss of consciousness, convulsions, anuria)
- •2.Women in the first trimester of pregnancy
- •3.Use of any anti-malarial drug other than sulphadoxine pyrimethamine less than 7 days before presentation
- •4.Other concurrent pregnancy related diseases e.g. urinary tract infections.
- •5.History of reaction to any of the drugs.
- •6.Patients not tolerating orally.
Investigators
Similar Trials
Completed
Not Applicable
To compare the response of children with sickle cell disease (SCD) and malaria to artemisinin combination therapy (ACT) antimalarials and the response of children without SCD treated with ACT for malariaSickle cell disease/malariaInfections and InfestationsPlasmodium falciparum malariaISRCTN96891086Danida Fellowship Centre (Denmark)120
Completed
Not Applicable
Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in MaliMalariaNL-OMON23822ondon School of Hygiene and Tropical Medicine80
Unknown
Phase 4
Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in SudanMalariaNCT01075945University of Khartoum140
Completed
Not Applicable
Monitoring Artemether-Lumefantrin (ALU) and Artesunate-Amodiaquin (AS-AQ) efficacy in uncomplicated malaria treatment in Bandiagara, and DoneguebougouMalariaPACTR201409000702188WANETAM/MRTC/DEAP/FMOS/USTTB320
Completed
Not Applicable
Artemisinin Combination Therapies (ACTs) efficacy for uncomplicated falciparum malaria treatment in Burkina FasoMalariaISRCTN90823663ational Malaria Control Program (Burkina Faso)780